공포증 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 공포증 종류별, 치료법별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Phobia Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type of Phobia, By Treatment, By End User, By Region, By Competition, 2020-2030F
상품코드:1878863
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 공포증 치료 시장은 2024년에 19억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 5.78%로 성장하여 26억 9,000만 달러에 달할 것으로 예측됩니다.
공포증 치료에는 특정 사물, 상황 또는 활동에 대한 강렬하고 비합리적인 두려움을 완화하기 위해 고안된 다양한 치료적 개입이 포함됩니다. 이러한 치료는 주로 인지행동치료, 노출치료 등의 심리치료를 주축으로 하며, 관련 증상 관리를 위해 항불안제, 항우울제 등의 약물 치료를 병행하는 경우가 많습니다. 시장 성장은 주로 전 세계적으로 정신질환에 대한 인식 개선과 편견 해소, 증거 기반 심리 중재에 대한 수요 증가, 디지털 기술 및 가상현실(VR) 기반 솔루션을 포함한 치료 방법의 지속적인 발전으로 뒷받침되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
19억 2,000만 달러
시장 규모 : 2030년
26억 9,000만 달러
CAGR : 2025-2030년
5.78%
가장 빠르게 성장하는 부문
치료
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 공포증 치료 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
공포증 종류별(동물공포증, 고소공포증, 광장공포증, 폐소공포증, 사회공포증, 기타)
치료법별(심리요법, 약물요법)
최종사용자별(병원, 정신과클리닉, 공포증 치료 센터, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 공포증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 공포증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 공포증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 공포증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 공포증 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 공포증 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Sanofi S.A
Cambrex Corporation
Teva Pharmaceutical Industries Ltd
Midas Pharma GmbH
Harman Finochem Ltd
Pfizer Inc.
AstraZeneca, Plc.
Eli Lilly and Company
Lupin Limited
GlaxoSmithKline plc
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Phobia Treatment Market , valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 5.78% to reach USD 2.69 Billion by 2030. Phobia treatment encompasses a variety of therapeutic interventions designed to alleviate intense and irrational fears of specific objects, situations, or activities. These treatments primarily involve psychotherapy, such as cognitive-behavioral therapy and exposure therapy, frequently complemented by pharmacotherapy, including anxiolytics and antidepressants, to manage associated symptoms. The market's growth is largely supported by increasing global awareness and destigmatization of mental health conditions, a rising demand for evidence-based psychological interventions, and ongoing advancements in therapeutic modalities, including digital and virtual reality-based solutions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.92 Billion
Market Size 2030
USD 2.69 Billion
CAGR 2025-2030
5.78%
Fastest Growing Segment
Therapy
Largest Market
North America
Key Market Drivers
The increasing prevalence of phobia-related disorders and growing awareness of mental health are pivotal in driving the global phobia treatment market. As a subset of anxiety disorders, the widespread incidence of these conditions creates substantial demand for therapeutic interventions. According to the World Health Organization, in its September 2025 "Anxiety disorders" fact sheet, 359 million people globally were affected by anxiety disorders in 2021, signifying a pervasive need for effective treatment. This underlying requirement is actively met as growing awareness and acceptance encourage individuals to seek professional help. Proactive governmental and healthcare initiatives further bolster this shift away from stigmatization.
Key Market Challenges
The persistent limited access to specialized mental health professionals globally constitutes a significant challenge for the expansion of the phobia treatment market. Despite the high prevalence of phobias and increasing mental health awareness, a substantial portion of the affected population struggles to receive appropriate care. This access barrier directly curtails the availability and delivery of effective therapeutic interventions, such as cognitive-behavioral therapy and exposure therapy. According to the World Health Organization's Mental Health Atlas 2024, the global median for mental health workers was 13 per 100,000 people, but this figure demonstrates extreme disparities, with lower-income countries reporting as few as 1.1 specialized mental health workers per 100,000 people compared to 67.2 in high-income countries. Such a pronounced shortage of trained professionals, particularly in underserved regions, means that many individuals seeking treatment cannot initiate or sustain their care, thereby restricting the market's potential for growth and the overall reach of phobia treatment services.
Key Market Trends
The integration of Virtual Reality (VR) exposure therapy represents a transformative trend in the global phobia treatment market. This innovative approach provides immersive and controllable environments, allowing patients to safely and repeatedly confront their specific phobias, thereby overcoming the practical and logistical challenges associated with traditional in-vivo exposure. The growing clinical acceptance of this modality is evident, with the American Psychiatric Association, in its October 2023 article "Transforming Mental Health Care: The Rise of VR/AR Applications in Psychiatry," highlighting VR's broad applications in psychiatry, including its common use in immersive exposure therapy for phobias. This underscores the increasing relevance and endorsement of VR within the professional mental healthcare community.
Key Market Players
Sanofi S.A
Cambrex Corporation
Teva Pharmaceutical Industries Ltd
Midas Pharma GmbH
Harman Finochem Ltd
Pfizer Inc.
AstraZeneca, Plc.
Eli Lilly and Company
Lupin Limited
GlaxoSmithKline plc
Report Scope:
In this report, the Global Phobia Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Phobia Treatment Market , By Type of Phobia:
Zoophobia
Acrophobia
Agoraphobia
Claustrophobia
Social Phobia
Others
Phobia Treatment Market , By Treatment:
Therapy
Medication
Phobia Treatment Market , By End User:
Hospitals
Psychiatry Clinics
Phobia Treatment Centers
Others
Phobia Treatment Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Phobia Treatment Market .
Available Customizations:
Global Phobia Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Phobia Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)
5.2.2. By Treatment (Therapy, Medication)
5.2.3. By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Phobia Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Phobia
6.2.2. By Treatment
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Phobia Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Phobia
6.3.1.2.2. By Treatment
6.3.1.2.3. By End User
6.3.2. Canada Phobia Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Phobia
6.3.2.2.2. By Treatment
6.3.2.2.3. By End User
6.3.3. Mexico Phobia Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Phobia
6.3.3.2.2. By Treatment
6.3.3.2.3. By End User
7. Europe Phobia Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Phobia
7.2.2. By Treatment
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Phobia Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Phobia
7.3.1.2.2. By Treatment
7.3.1.2.3. By End User
7.3.2. France Phobia Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Phobia
7.3.2.2.2. By Treatment
7.3.2.2.3. By End User
7.3.3. United Kingdom Phobia Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Phobia
7.3.3.2.2. By Treatment
7.3.3.2.3. By End User
7.3.4. Italy Phobia Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Phobia
7.3.4.2.2. By Treatment
7.3.4.2.3. By End User
7.3.5. Spain Phobia Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Phobia
7.3.5.2.2. By Treatment
7.3.5.2.3. By End User
8. Asia Pacific Phobia Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Phobia
8.2.2. By Treatment
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Phobia Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Phobia
8.3.1.2.2. By Treatment
8.3.1.2.3. By End User
8.3.2. India Phobia Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Phobia
8.3.2.2.2. By Treatment
8.3.2.2.3. By End User
8.3.3. Japan Phobia Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Phobia
8.3.3.2.2. By Treatment
8.3.3.2.3. By End User
8.3.4. South Korea Phobia Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Phobia
8.3.4.2.2. By Treatment
8.3.4.2.3. By End User
8.3.5. Australia Phobia Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Phobia
8.3.5.2.2. By Treatment
8.3.5.2.3. By End User
9. Middle East & Africa Phobia Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Phobia
9.2.2. By Treatment
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Phobia Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Phobia
9.3.1.2.2. By Treatment
9.3.1.2.3. By End User
9.3.2. UAE Phobia Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Phobia
9.3.2.2.2. By Treatment
9.3.2.2.3. By End User
9.3.3. South Africa Phobia Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Phobia
9.3.3.2.2. By Treatment
9.3.3.2.3. By End User
10. South America Phobia Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Phobia
10.2.2. By Treatment
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Phobia Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Phobia
10.3.1.2.2. By Treatment
10.3.1.2.3. By End User
10.3.2. Colombia Phobia Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Phobia
10.3.2.2.2. By Treatment
10.3.2.2.3. By End User
10.3.3. Argentina Phobia Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Phobia
10.3.3.2.2. By Treatment
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Phobia Treatment Market : SWOT Analysis
